Skip to main content

Conference Program

Subpage Hero


Genetic Testing for Rare Diseases of Obesity (This activity is supported by Rhythm Pharmaceuticals, Inc)

13 Mar 2024
Venue: Metro Toronto Convention Center
Meeting Room: 701 B
Corporate Educational Satellite Symposia are independently developed and supported by ACMG’s industry partners and offer additional valuable educational opportunities for attendees.
This Genetic Obesity Learning Development (GOLD) Academy program will allow participants to differentiate rare MC4R pathway diseases of obesity from general obesity. Geneticists and genetic counselors will learn key clinical characteristics of rare MC4R pathway diseases of obesity for diagnosis and to identify patients suitable for genetic testing.
Vidhu Thaker, MD, Columbia University, Irving Medical Center

Corporate Satellite Symposia are not part of the official ACMG program and are open to all attendees.
Pre-registration is required. 
For more information and to register

Learning Objectives:
  • Introduce rare melanocortin-4 receptor (MC4R) pathway diseases
  • Illustrate how rare variants in key MC4R pathway genes impact body weight
  • Discuss diagnosis of melanocortin-4 receptor (MC4R) pathway diseases associated with obesity
  • Discuss the role of genetic testing in rare genetic diseases of obesity